Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.globenewswire.com/news-release/2023/06/24/2693972/0/en/Enterin-Presents-Data-Demonstrating-Strong-Benefit-of-ENT-03-on-Body-Weight-Adiposity-and-Blood-Glucose-Vs-Semaglutide-in-a-Diet-Induced-Obesity-Mouse-Model.html
0
0
Enterin Presents Data Demonstrating Strong Benefit of ENT-03 on Body Weight, Adiposity and Blood Glucose Vs. Semaglutide in a Diet Induced Obesity Mouse Model - GlobeNewswire
6/24/23 at 12:00pm
Organization
GlobeNewswire
Authors
Enterin
Inc.
36 words
0
Comments
Data presented at the American Diabetes Association 83rd Scientific Sessions......
general
Health Conditions
Enterin Presents Data Demonstrating Strong Benefit of ENT-03
Blood Glucose Vs. Semaglutide
American Diabetes Association
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...